Methodist Hospital — Omaha, Nebraska

Methodist Hospital is a clinical research site located in Omaha, Nebraska, United States 68114.

Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

Methodist Hospital has participated in 7 clinical trials with 1 currently active.

Therapeutic areas: High Grade Serous Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer.

Sponsors: Mersana Therapeutics, Anesiva, Inc., Pfizer.

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Methodist Hospital?

Methodist Hospital has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Methodist Hospital conducted?

Methodist Hospital has 7 clinical trials on record, with 1 currently active. Their work covers High Grade Serous Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer.

Is Methodist Hospital accredited by Crixeo Health?

Yes — Methodist Hospital holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Methodist Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.